Prostate-specific antigen-activated thapsigargin prodrug as targeted therapy for prostate cancer.

Prostate-specific antigen-activated thapsigargin prodrug as targeted therapy for prostate cancer.

BACKGROUND: Standard anti-proliferative chemotherapy is relatively ineffective against slowly proliferating androgen-independent prostate cancer cells within metastatic sites. In contrast, the lipophilic cytotoxin thapsigargin, which causes apoptosis by disrupting intracellular free Ca2+ levels, is...

Full beskrivning

Bibliografiska uppgifter
Huvudupphovsmän:	Denmeade, SR, Jakobsen, C, Janssen, S, Khan, SR, Garrett, E, Lilja, H, Christensen, S, Isaacs, J
Materialtyp:	Journal article
Språk:	English
Publicerad:	2003

Liknande verk

Pharmacokinetics, biodistribution, and antitumor efficacy of a human glandular kallikrein 2 (hK2)-activated thapsigargin prodrug.
av: Janssen, S, et al.
Publicerad: (2006)

Screening a combinatorial peptide library to develop a human glandular kallikrein 2-activated prodrug as targeted therapy for prostate cancer.
av: Janssen, S, et al.
Publicerad: (2004)

Mipsagargin: The Beginning—Not the End—of Thapsigargin Prodrug-Based Cancer Therapeutics
av: John T. Isaacs, et al.
Publicerad: (2021-12-01)

Prostate-specific antigen (PSA) protein does not affect growth of prostate cancer cells in vitro or prostate cancer xenografts in vivo.
av: Denmeade, SR, et al.
Publicerad: (2003)

Molecular insights into substrate specificity of prostate specific antigen through structural modeling.
av: Singh, P, et al.
Publicerad: (2009)

Biology of prostate-specific antigen
av: Lilja, H
Publicerad: (2003)

Biology of prostate-specific antigen.
av: Lilja, H
Publicerad: (2003)

Prostate-specific antigen and prostate cancer: prediction, detection and monitoring.
av: Lilja, H, et al.
Publicerad: (2008)

Early prostate-specific antigen changes and the diagnosis and prognosis of prostate cancer.
av: Botchorishvili, G, et al.
Publicerad: (2009)

Prostate-specific antigen and related isoforms in the diagnosis and management of prostate cancer.
av: Haese, A, et al.
Publicerad: (2004)

[Isoforms of free prostate-specific antigen]
av: Haese, A, et al.
Publicerad: (2004)

Isoforms of free prostate-specific antigen
av: Haese, A, et al.
Publicerad: (2004)

Targeting free prostate-specific antigen for in vivo imaging of prostate cancer using a monoclonal antibody specific for unique epitopes accessible on free prostate-specific antigen alone.
av: Evans-Axelsson, S, et al.
Publicerad: (2012)

An empirical evaluation of guidelines on prostate-specific antigen velocity in prostate cancer detection.
av: Vickers, A, et al.
Publicerad: (2011)

On the use of prostate-specific antigen for screening of prostate cancer in European Randomised Study for Screening of Prostate Cancer.
av: Bangma, C, et al.
Publicerad: (2010)

Systematic review of pretreatment prostate-specific antigen velocity and doubling time as predictors for prostate cancer.
av: Vickers, A, et al.
Publicerad: (2009)

Cumulative prostate cancer risk assessment with the aid of the free-to-total prostate specific antigen ratio.
av: Aus, G, et al.
Publicerad: (2004)

Activation of latent protease function of pro-hK2, but not pro-PSA, involves autoprocessing.
av: Denmeade, SR, et al.
Publicerad: (2001)

The relationship between prostate-specific antigen and prostate cancer risk: the Prostate Biopsy Collaborative Group.
av: Vickers, A, et al.
Publicerad: (2010)

Synthesis of the thapsigargins.
av: Ley, S, et al.
Publicerad: (2004)

Targeted delivery of a cisplatin prodrug for safer and more effective prostate cancer therapy in vivo
av: Dhar, Shanta, et al.
Publicerad: (2011)

Prostate-specific antigen and prostate cancer: Prediction, detection and monitoring (Corrigendum) (Nature Reviews Cancer (2008) 8, (268-278))
av: Lilja, H, et al.
Publicerad: (2008)

Anti-thrombin is expressed in the benign prostatic epithelium and in prostate cancer and is capable of forming complexes with prostate-specific antigen and human glandular kallikrein 2.
av: Cao, Y, et al.
Publicerad: (2002)

Lutetium-177-Labeled Prostate-Specific Membrane Antigen-617 for Molecular Imaging and Targeted Radioligand Therapy of Prostate Cancer
av: Rien Ritawidya, et al.
Publicerad: (2023-11-01)

Population-based screening for prostate cancer by measuring free and total serum prostate-specific antigen in Sweden.
av: Hugosson, J, et al.
Publicerad: (2003)

Variation in percentage-free prostate-specific antigen (PSA) with prostate volume, age and total PSA level.
av: Törnblom, M, et al.
Publicerad: (2001)

The Impact of prostate – Specific Antigen Density In Predicting Prostate Cancer
av: Abdul-Kareem Sh. Al-Khafaji, et al.
Publicerad: (2019-11-01)

The Impact of prostate – Specific Antigen Density In Predicting Prostate Cancer
av: Abdul-Kareem Sh. Al-Khafaji, et al.
Publicerad: (2019-11-01)

First report of prostate-specific membrane antigen-targeted immunotherapy in prostate cancer: the future is bright
av: Lamb, A, et al.
Publicerad: (2018)

Follow-up of men with elevated prostate-specific antigen and one set of benign biopsies at prostate cancer screening.
av: Zackrisson, B, et al.
Publicerad: (2003)

Testing in serum for human glandular kallikrein 2, and free and total prostate specific antigen in biannual screening for prostate cancer
av: Becker, C, et al.
Publicerad: (2003)

Testing in serum for human glandular kallikrein 2, and free and total prostate specific antigen in biannual screening for prostate cancer.
av: Becker, C, et al.
Publicerad: (2003)

Time-resolved fluorescence imaging for specific and quantitative immunodetection of human kallikrein 2 and prostate-specific antigen in prostatic tissue sections.
av: Siivola, P, et al.
Publicerad: (2000)

Prostate specific antigen velocity does not aid prostate cancer detection in men with prior negative biopsy.
av: Vickers, A, et al.
Publicerad: (2010)

Prostate specific antigen based biennial screening is sufficient to detect almost all prostate cancers while still curable.
av: Hugosson, J, et al.
Publicerad: (2003)

Imaging androgen receptor signaling with a radiotracer targeting free prostate-specific antigen.
av: Ulmert, D, et al.
Publicerad: (2012)

The continuing role of prostate-specific antigen as a marker for localized prostate cancer: 'do not throw the baby out with the bath water'.
av: Challacombe, B, et al.
Publicerad: (2009)

Assessment of intra-individual variation in prostate-specific antigen levels in a biennial randomized prostate cancer screening program in Sweden.
av: Bruun, L, et al.
Publicerad: (2005)

Prostate specific antigen concentration at age 60 and death or metastasis from prostate cancer: case-control study.
av: Vickers, A, et al.
Publicerad: (2010)

Prostate specific antigen concentration at age 60 and death or metastasis from prostate cancer: Case-control study
av: Vickers, A, et al.
Publicerad: (2010)